Business Description
Kaleido Biosciences Inc
NAICS : 325412
SIC : 2836
ISIN : US4833471000
Compare
Compare
Traded in other countries / regions
KLDO.USA Index Membership
Russell 2000 IPO Date
2019-02-28Description
Kaleido Biosciences Inc is a clinical-stage healthcare company. It is focused on leveraging the potential of the microbiome organ to treat disease and improve human health. Its product candidates are Microbiome Metabolic Therapies, or MMTs, which are designed to modulate the metabolic output and profile of the microbiome.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 39.08 | |||||
9-Day RSI | 44.49 | |||||
14-Day RSI | 46.84 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
FCF Margin % | -7085.42 | |||||
OCF Margin % | -6983.15 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
EV-to-EBIT | 0.19 | |||||
EV-to-EBITDA | 0.2 | |||||
EV-to-Revenue | -15.2 | |||||
EV-to-Forward-Revenue | 1.28 | |||||
EV-to-FCF | 0.21 | |||||
Earnings Yield (Greenblatt) % | 526.32 | |||||
FCF Yield % | -147800 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:KLDO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Kaleido Biosciences Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 1.104 | ||
| EPS (TTM) ($) | -2.16 | ||
| Beta | 19.3833 | ||
| 3-Year Sharpe Ratio | 0.95 | ||
| 3-Year Sortino Ratio | 11.33 | ||
| Volatility % | - | ||
| 14-Day RSI | 46.84 | ||
| 14-Day ATR ($) | 0.009239 | ||
| 20-Day SMA ($) | 0.00012 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range ($) | 0.00001 - 0.20005 | ||
| Shares Outstanding (Mil) | 42.62 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Kaleido Biosciences Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Kaleido Biosciences Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-16 | In 142 days | ||
| Second quarter earnings results for 2026 | 2026-08-14 | In 48 days | ||
| First quarter earnings results for 2026 | 2026-07-06 | In 9 days | ||
| Annual report for 2025 | 2026-06-29 | In 2 days | ||
| General meeting for 2025 | 2026-06-29 | In 2 days |
Show
Entries
Kaleido Biosciences Inc Frequently Asked Questions
What is Kaleido Biosciences Inc(KLDO)'s stock price today?
The current price of KLDO is $0.00. The 52 week high of KLDO is $0.20 and 52 week low is $0.00.
When is next earnings date of Kaleido Biosciences Inc(KLDO)?
The next earnings date of Kaleido Biosciences Inc(KLDO) is 2026-07-06 Est..
Does Kaleido Biosciences Inc(KLDO) pay dividends? If so, how much?
Kaleido Biosciences Inc(KLDO) does not pay dividend.
Guru Commentaries on OTCPK:KLDO
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Kaleido Biosciences Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers